Consistent with this notion, Mazurek et al. found that silencing DDX5 in acute myeloid leukemia (AML) cells induces glycolysis dysregulation, elevates ROS production and induces apoptosis by downregulating the expression of glucose metabolism-relevant genes [78]. The gene discussed is DDX5; the disease is acute myeloid leukemia.